Florida Cancer Specialists & Research Institute and Cigna Expand Cancer Care Collaboration
Enhanced program features treatment of all cancer diagnoses, additional treatment therapies
Fort Myers, FLA., August 13, 2019 — Florida Cancer Specialists & Research Institute (FCS) and Cigna are pleased to announce an important oncology focused initiative. The program is part of Cigna Collaborative Care, a value-based care model that uses incentives to engage health care professionals to improve patient health, affordability and overall patient experience. The program, titled Cigna Oncology Focus program, started in July and is focused on quality and containing costs for people fighting cancer. FCS and Cigna announced the first phase of their collaborative care arrangement in 2015.
The original phase of the Cigna Collaborative Care program consisted of multiple components, with FCS managing patients’ treatment with 24/7 access to an oncology certified nurse who assists patients and ensures appropriate care coordination, and Cigna providing extra support, education, information and reducing unnecessary ER visits and hospitalization.
“With the Cigna Oncology Focus program, patients benefit from two significant program enhancements,” said Dr. Lucio Gordan, president and managing physician for Florida Cancer Specialists. “Those changes involve the inclusion of all categories of cancer diagnoses, versus a previous focus of breast, lung and colorectal cancers, leukemia and lymphoma. Also, the program includes the availability of additional therapy treatments for more types of cancers than previously,” he concluded.
“We are committed to continuously supporting our patients,” said FCS CEO Brad Prechtl, MBA. “We recognize that a collaborative approach to managing cancer care works, allowing us to increase the best possible patient outcomes and experience.”
Sarah Cevallos, FCS Chief Revenue Cycle Officer, noted that “Cigna has been an instrumental payer as our pioneer value-based care partner, since 2016, when we started our initial program. Through our collaboration, we have had tremendous success learning from each other with results that have shown a 28% lower inpatient admission rate compared to typical hospital admission rates of cancer patients outside of a value-based model of care like this. This next generation program builds upon this success and we are thrilled to expand this partnership even further to touch more Cigna patients.”
"Our priority is to ensure high quality care for our customers who are going through a difficult journey, and we continue to see substantial improvements in patient experience and efficiency from our collaborative with Florida Cancer Specialists," said Michael Howell, M.D., Market Medical Executive for Cigna in Florida. "Our successful model includes a care coordinator to help patients get the follow-up care they need, great clinical outreach, and incentives that compensate physicians for the value of the care they deliver.”
About Florida Cancer Specialists & Research Institute, LLC: (FLCancer.com)
Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida. In the past 4 years, the majority of new cancer drugs approved for use in the U.S. were studied in clinical trials with Florida Cancer Specialists participation.* Trained in such prestigious medical schools and research institutes as Duke, Stanford, Harvard, Emory, M.D. Anderson, and Memorial Sloan Kettering, our physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report.
Founded in 1984, FCS is one of the largest medical oncology/hematology practices in the United States. With more than 230 physicians, 220 advanced practice registered nurses (APRN) and physician assistants (PA) and nearly 100 locations in our network, we are committed to providing world-class cancer care in community-based settings, close to home.
Florida Cancer Specialists has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research, cutting-edge technologies and advanced treatments, including targeted therapies, genomic-based treatment, and immunotherapy. Our highest values are embodied by our outstanding team of highly-trained and dedicated physicians, clinicians and staff.
*Prior to approval
For More Information, Contact:
Florida Cancer Specialists & Research Institute
Shelly Glenn, Chief Marketing & Sales Officer
Michelle Robey, Director of Marketing & Communications
Cigna Corporation (NYSE: CI) is a global health service company dedicated to improving the health, well-being and peace of mind of those we serve. Cigna delivers choice, predictability, affordability and access to quality care through integrated capabilities and connected, personalized solutions that advance whole person health. All products and services are provided exclusively by or through operating subsidiaries of Cigna Corporation, including Cigna Health and Life Insurance Company, Connecticut General Life Insurance Company, Life Insurance Company of North America, Cigna Life Insurance Company of New York, Express Scripts companies or their affiliates.
Such products and services include an integrated suite of health services, such as medical, dental, behavioral health, pharmacy, vision, supplemental benefits, and other related products including group life, accident and disability insurance.
Cigna maintains sales capability in over 30 countries and jurisdictions, and has 165 million customer relationships worldwide. To learn more about Cigna®, including links to follow us on Facebook or Twitter, visit www.cigna.com.